COIOSDeep risk insights through multi-disciplinary research across the globe
a crowd of people in a city
Item confirms Preprint · not peer-reviewed Added

Hospitalised Brazilian influenza patients with two vaccine doses had 32% lower mortality

Among Brazilians hospitalised with influenza between 2023 and October 2025, two trivalent vaccine doses within a calendar year were associated with 32% lower in-hospital mortality and 52% fewer ICU admissions.

Brazilian surveillance records of patients hospitalised with confirmed influenza were analysed from 2023 to October 2025, as vaccine uptake fell from about 70% to 40-50%. Two trivalent doses within a calendar year were associated with 32% lower in-hospital mortality and 52% fewer ICU admissions. A single dose was associated with reductions of 10-13% across the same measures.

Why it is interesting: All patients were already in hospital, so the comparison is of severity rather than of infection.

Source
medRxiv, 21 September 2026
Paper
Protective effect of influenza vaccine in Brazilian patients hospitalised for severe acute respiratory infection, 2023-2025
Authors
Kupek E
DOI
10.64898/2026.09.15.26362995
Type
Preprint
Design
Retrospective analysis of Brazilian SARI hospitalisation surveillance records, 2023 to October 2025, Poisson regression on vaccine doses received per calendar year
Verdict
Confirms prior evidence
Driver
Infection and pandemics
Abstract — the authors' own words, CC BY

Introduction

Despite a significant increase in influenza burden in Brazil in 2025, influenza vaccine effectiveness has not included the key end-of-winter period so far. Methods:

The key exposure measure was the number of trivalent influenza vaccine doses received within a calendar year. In-hospital mortality and length of stay, use of the intensive care unit (ICU), and ICU stay were outcome measures. Secondary data from January 2003 to October 2025 were retrieved and analysed by Poisson regression. Results

Influenza vaccine uptake among SARI-hospitalised patients dropped from about 70% in 2023 to a 40-50% level in 2024 and 2025. A single vaccine dose reduced outcomes by 10-13% compared to unvaccinated patients. Two doses per year significantly reduced mortality (32%), ICU admissions (52%), and ICU stay (28%). Conclusion

Two doses of influenza vaccine were moderately effective in decreasing in-hospital mortality and stay among SARI-hospitalised influenza patients. Including 50-59-year-olds in a priority vaccination group may significantly reduce influenza-related adverse outcomes.

Other drivers in Behavioural science